BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34862598)

  • 1. Validation of four cutaneous squamous cell carcinoma staging systems using nationwide data.
    Venables ZC; Tokez S; Hollestein LM; Mooyaart AL; van den Bos RR; Rous B; Leigh IM; Nijsten T; Wakkee M
    Br J Dermatol; 2022 May; 186(5):835-842. PubMed ID: 34862598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.
    Roscher I; Falk RS; Vos L; Clausen OPF; Helsing P; Gjersvik P; Robsahm TE
    JAMA Dermatol; 2018 Apr; 154(4):428-434. PubMed ID: 29516080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Salamanca refinement of the T3-AJCC8 versus the Brigham and Women's Hospital and Tübingen alternative staging systems for high-risk cutaneous squamous cell carcinoma.
    Puebla-Tornero L; Corchete-Sánchez LA; Conde-Ferreirós A; García-Sancha N; Corchado-Cobos R; Román-Curto C; Cañueto J
    J Am Acad Dermatol; 2021 Apr; 84(4):938-945. PubMed ID: 33333151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stratification of Poor Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients Using the American Joint Committee on Cancer Eighth Edition and Brigham and Women's Hospital Staging Systems.
    Blechman AB; Carucci JA; Stevenson ML
    Dermatol Surg; 2019 Sep; 45(9):1117-1124. PubMed ID: 30640779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brigham and Women's Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death.
    Morgan FC; Ruiz ES; Karia PS; Besaw RJ; Neel VA; Schmults CD
    J Am Acad Dermatol; 2021 Sep; 85(3):582-587. PubMed ID: 33497751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of tumor staging systems for cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.
    Inda JJ; Kabat BF; Larson MC; Slager SL; Baum CL
    J Am Acad Dermatol; 2019 Mar; 80(3):639-645. PubMed ID: 30165169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma.
    Karia PS; Jambusaria-Pahlajani A; Harrington DP; Murphy GF; Qureshi AA; Schmults CD
    J Clin Oncol; 2014 Feb; 32(4):327-34. PubMed ID: 24366933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous squamous cell carcinoma staging may influence management in users: A survey study.
    Patel VA; McCullum C; Sparks AD; Schmults CD; Arron ST; Jambusaria-Pahlajani A
    Cancer Med; 2022 Jan; 11(1):94-103. PubMed ID: 34796670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma.
    Ruiz ES; Karia PS; Besaw R; Schmults CD
    JAMA Dermatol; 2019 Jul; 155(7):819-825. PubMed ID: 30969315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model.
    Rentroia-Pacheco B; Tokez S; Bramer EM; Venables ZC; van de Werken HJG; Bellomo D; van Klaveren D; Mooyaart AL; Hollestein LM; Wakkee M
    EClinicalMedicine; 2023 Sep; 63():102150. PubMed ID: 37662519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Tumor Staging: Predicting Nodal Metastases in Cutaneous Squamous Cell Carcinoma.
    Upton M; Kita A; Scapa J; St John M
    Laryngoscope; 2021 Jan; 131(1):E170-E175. PubMed ID: 32212346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice.
    Cañueto J; Burguillo J; Moyano-Bueno D; Viñolas-Cuadros A; Conde-Ferreirós A; Corchete-Sánchez LA; Pérez-Losada J; Román-Curto C
    J Am Acad Dermatol; 2019 Jan; 80(1):106-113.e2. PubMed ID: 30003984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
    Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Fargnoli MC; Forsea AM; Frenard C; Harwood CΑ; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
    Eur J Cancer; 2020 Mar; 128():60-82. PubMed ID: 32113941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Value of Sentinel Lymph Node Biopsy in Cutaneous Squamous Cell Carcinoma Based on the AJCC-8 and Brigham and Women's Hospital Staging Criteria.
    Tejera-Vaquerizo A; Cañueto J; Llombart B; Martorell-Calatayud A; Sanmartín O
    Dermatol Surg; 2020 Jul; 46(7):857-862. PubMed ID: 31567487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the American Joint Committee on Cancer Seventh Edition and Brigham and Women's Hospital Cutaneous Squamous Cell Carcinoma Tumor Staging in Immunosuppressed Patients.
    Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM
    Dermatol Surg; 2017 Jun; 43(6):784-791. PubMed ID: 28079640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.
    Tschetter AJ; Campoli MR; Zitelli JA; Brodland DG
    J Am Acad Dermatol; 2020 Jan; 82(1):139-148. PubMed ID: 31279037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of Satellitosis or In-transit Metastasis in Cutaneous Squamous Cell Carcinoma: A Prognostic Omission in Cancer Staging Systems.
    Smile TD; Ruiz ES; Kus KJB; Murad F; Wei W; Xiong DD; Vidimos AT; Schmults CD; Koyfman SA
    JAMA Dermatol; 2022 Apr; 158(4):390-394. PubMed ID: 35195668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis and Comparison of the 8th Edition American Joint Committee on Cancer (AJCC) Nodal Staging System in Cutaneous and Oral Squamous Cell Cancer of the Head and Neck.
    Moeckelmann N; Ebrahimi A; Dirven R; Liu J; Low TH; Gupta R; Ashford B; Ch'ng S; Palme CE; Clark JR
    Ann Surg Oncol; 2018 Jun; 25(6):1730-1736. PubMed ID: 29352431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive Perineural Invasion vs Nerve Caliber to Assess Cutaneous Squamous Cell Carcinoma Prognosis.
    Massey PR; Wang DM; Murad F; Mulvaney P; Moore K; Okhovat JP; Russell-Goldman E; Lin WM; Piris A; Huilgol SC; Ruiz ES; Schmults CD
    JAMA Dermatol; 2023 Dec; 159(12):1332-1338. PubMed ID: 37851425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
    Burton KA; Ashack KA; Khachemoune A
    Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.